Vitamin A Value of Spirulina Carotenoids in Humans
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this protocol is to determine the vitamin A value (equivalence) of spirulina. The investigation will use intrinsically deuterium labeled spirulina and an isotope vitamin A reference dose, 13C10- retinyl acetate (13C10 RAc), in males (n=20). Up to 45 blood samples (10 ml/sample) will be collected from each subject over a two-month period to evaluate the bioavailability and bioconversion of spirulina ß-carotene to vitamin A.
| Condition | Intervention | Phase |
|---|---|---|
|
Intrinsically Labeled Spirulina |
Dietary Supplement: spirulina ß-carotene |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Bio-equivalence Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
| Official Title: | Vitamin A Value of Spirulina Carotenoids in Humans |
- The enrichment of spirulina ß-carotene and its cleavage product vitamin A were tracked after taken the oral dose of intrinsically labeled spirulina. [ Time Frame: 51 days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 20 |
| Study Start Date: | April 2004 |
| Estimated Study Completion Date: | May 2009 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 |
Dietary Supplement: spirulina ß-carotene
an acute dose of spirulina up to 5 g
Other Name: spirulina VA study
Dietary Supplement: spirulina ß-carotene
vitamin A value of spirulina ß-carotene
Other Name: spirulina VA study
|
| Experimental: 2 |
Dietary Supplement: spirulina ß-carotene
an acute dose of spirulina up to 5 g
Other Name: spirulina VA study
Dietary Supplement: spirulina ß-carotene
vitamin A value of spirulina ß-carotene
Other Name: spirulina VA study
|
Detailed Description:
By utilizing novel stable isotope dilution techniques recently developed in our laboratory, we will trace deuterium labeled ß-carotene in intrinsically labeled spirulina, which is harvested from a hydroponic system. In the mean time, we will track 13C10 labeled vitamin A in humans. In this way we will determine absorption of ß-carotene from spirulina matrix and the conversion of the spirulina ß-Carotene to retinol. This will enable us quantitatively determine the vitamin A equivalence of spirulina.
The specific aims of this study are:
- To determine labeled ß-C blood response kinetics following an acute dose of intrinsically labeled spirulina;
- To determine labeled retinol blood response from the intrinsically labeled spirulina;
- To determine 13C10 retinol blood response from the isotope reference material 13C10 retinyl acetate;
- To determine s spirulina-vitamin A equivalence.
Eligibility| Ages Eligible for Study: | 40 Years to 70 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy volunteer
Exclusion Criteria:
- Not has GI track problems
- Any medical condition that will affect the intestinal absorption
Contacts and Locations| United States, Massachusetts | |
| USDA Human Nutrition Research Center on Aging, Tufts Uni. | |
| Boston, Massachusetts, United States, 02111 | |
| Principal Investigator: | Guangwen Tang, Ph.D. | USDA Human Nutrition Research Center on Aging, Tufts University |
More Information
No publications provided
| Responsible Party: | Guangwen Tang, Tufts University |
| ClinicalTrials.gov Identifier: | NCT00680277 History of Changes |
| Other Study ID Numbers: | PV2270 |
| Study First Received: | May 16, 2008 |
| Last Updated: | September 22, 2009 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Tufts University:
|
spirulina carotenoids |
Additional relevant MeSH terms:
|
Carotenoids Retinol palmitate Vitamin A Vitamins Antioxidants Molecular Mechanisms of Pharmacological Action Pharmacologic Actions |
Protective Agents Physiological Effects of Drugs Micronutrients Growth Substances Anticarcinogenic Agents Antineoplastic Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 16, 2013